Immedica Pharma
Manufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Solnavägen 3h, Stockholm, Stockholm, 113...Phone Number
+46 853339500Website
www.immedica.comRevenue
$67.5 MillionIndustry
About Immedica Pharma
Immedica Pharma Org Chart
Director, Commercial Saudia Arabia
Director, Medical Affairs
Regional Medical Director
Regional Medical Director
Is Immedica Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Immedica Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Immedica Pharma launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Immedica Pharma recently announced quarterly report
Click to see if Immedica Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Immedica Pharma
Immedica Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Immedica Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Immedica Pharma is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Immedica Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immedica Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immedica Pharma.
Immedica Pharma Tech Stack
A closer look at the technologies used by Immedica Pharma
Most Recent Scoops
Immedica Pharma News & Media
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costs Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costsCVC Credit provides debt facilities for the joint acquisition of Immedica Pharma by KKR and Impilo
CVC Credit, the €41 billion global credit management business of CVC, is pleased to announce that it has provided debt facilities to support the joint acquisition of Immedica Pharma (“Immedica”), a leading Swedish pharmaceutical company, by global investment firm KKR and Nordic healthcare investment firm Impilo.Sweden: Immedica to acquire all shares in Marinus Pharmaceuticals
Immedica to acquire all shares in Marinus Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immedica Pharma
Immedica Pharma is a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization and distribution of medicines for rare and specialty diseases. The company operates with a patient-centered mission, aiming to address significant unmet medical needs in therapeutic areas such as genetic and metabolic disorders, hematolo... Read More